Drug
tremelimumab
Marketed as IMJUDO.
Generic name
tremelimumab
Brand names
IMJUDO
First FDA approval
2022-10-21
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761289 | IMJUDO | 2022-10-21 | ASTRAZENECA AB |
Manufacturers
ASTRAZENECA AB
Frequently asked questions
When was tremelimumab FDA approved?
Earliest FDA approval on record: 2022-10-21.
What brand names are sold as tremelimumab?
IMJUDO.
Sources
Appeal a tremelimumab denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com